In November, 79 new cases were added to the Ozempic MDL (Multidistrict Litigation), bringing the total number of filings to over 200 in just the past two months. The MDL [...]
Last week, attorneys representing plaintiffs in the Ozempic lawsuits filed a revised master complaint in the MDL (Multidistrict Litigation). This updated document refines the allegations against the defendants that include [...]
As the number of cases in the Ozempic MDL continues to rise, new filings are focusing on the claim that Novo Nordisk purposely minimized the risks of gastroparesis in its [...]
The court has scheduled early discovery and motion practice focused on preemption and the adequacy of warning labels in the Ozempic lawsuits. However, the issue of marketing discovery has not [...]
